176 related articles for article (PubMed ID: 37853604)
1. Bulevirtide and emerging drugs for the treatment of hepatitis D. Xu HY; Yang JO; Chen PH; Han SB Expert Opin Biol Ther; 2023; 23(12):1245-1253. PubMed ID: 37853604 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis D: A Review. Negro F; Lok AS JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548 [TBL] [Abstract][Full Text] [Related]
3. Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta. Deterding K; Wedemeyer H AIDS Rev; 2019; 21(3):126-134. PubMed ID: 31532397 [TBL] [Abstract][Full Text] [Related]
4. Bulevirtide for patients with compensated chronic hepatitis delta: A review. Degasperi E; Anolli MP; Lampertico P Liver Int; 2023 Aug; 43 Suppl 1():80-86. PubMed ID: 35942695 [TBL] [Abstract][Full Text] [Related]
5. [Bulevirtide as the first specific agent against hepatitis D virus infections-mechanism and clinical effect]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; ; . PubMed ID: 35028672 [TBL] [Abstract][Full Text] [Related]
